Cargando…

HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide

BACKGROUND: Management of multidrug-resistant TB (MDR-TB) patients co-infected with human immunodeficiency virus (HIV) is highly challenging. Such patients are subject to long and potentially toxic treatments and may develop a number of different psychiatric illnesses such as anxiety and depressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Mrinalini, Isaakidis, Petros, Van den Bergh, Rafael, Kumar, Ajay MV, Nagaraja, Sharath Burugina, Valikayath, Asmaa, Jha, Santosh, Jadhav, Bindoo, Ladomirska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Co-Action Publishing 2014
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161725/ https://www.ncbi.nlm.nih.gov/pubmed/25215909 http://dx.doi.org/10.3402/gha.v7.24912

Ejemplares similares

Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review
por: Padmapriyadarsini, C., et al.
Publicado: (2018)

Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia
por: Khann, Sokhan, et al.
Publicado: (2013)

“When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention
por: Shringarpure, Kalpita S., et al.
Publicado: (2016)

Uprooted by COVID pandemic: National TB elimination programme needs acceleration!
por: Nagaraja, Sharath Burugina, et al.
Publicado: (2021)

Predictors and Timing of ATT Initiation among HIV-TB Patients at ART Centers of Karnataka, India: Two Year Follow-Up
por: Shastri, Suresh, et al.
Publicado: (2015)

TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?
por: Ilangovan, Kumaravel, et al.
Publicado: (2015)

Mandatory TB notification in Mysore city, India: Have we heard the private practitioner’s plea?
por: Singh Chadha, Sarabjit, et al.
Publicado: (2017)

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2012)

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
por: Benbaba, Stella, et al.
Publicado: (2015)

Engaging Informal Private Health Care Providers for TB Case Detection: Experiences from RIPEND Project in India
por: Kelamane, Santosha, et al.
Publicado: (2021)

Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India
por: Kanakaraju, Manjula, et al.
Publicado: (2020)

The journey to antiretroviral therapy in Karnataka, India: who was lost on the road?
por: Shastri, Suresh, et al.
Publicado: (2013)

Screening for Severe Illness at Diagnosis Has the Potential to Prevent Early TB Deaths: Programmatic Experience From Karnataka, India
por: Shewade, Hemant Deepak, et al.
Publicado: (2022)

TB Notification from Private Health Sector in Delhi, India: Challenges Encountered by Programme Personnel and Private Health Care Providers
por: Satpati, Mahasweta, et al.
Publicado: (2017)

Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It
por: Shringarpure, Kalpita S., et al.
Publicado: (2015)

Tuberculosis screening for pediatric household contacts in India: Time to adapt newer strategies under the National TB Elimination Programme!
por: Chawla, Kiran, et al.
Publicado: (2023)

Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges
por: Chavan, Vijay Vinayak, et al.
Publicado: (2020)

Feasibility and Effectiveness of Provider Initiated HIV Testing and Counseling of TB Suspects in Vizianagaram District, South India
por: Achanta, Shanta, et al.
Publicado: (2012)

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
por: Dhakulkar, Shubhangi, et al.
Publicado: (2021)

Does mobile phone instructional video demonstrating sputum expectoration improve the sputum sample quality and quantity in presumptive pulmonary TB cases? Protocol for a prospective pragmatic non-randomised controlled trial in Karnataka state, India
por: Shivalli, Siddharudha, et al.
Publicado: (2020)

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
por: Das, Mrinalini, et al.
Publicado: (2021)

Risk factors for the development of tuberculosis among the pediatric population: a systematic review and meta-analysis
por: Siddalingaiah, Nayana, et al.
Publicado: (2023)

“Who has to do it at the end of the day? Programme officials or hospital authorities?” Airborne infection control at drug resistant tuberculosis (DR-TB) centres of Karnataka, India: a mixed-methods study
por: Akshaya, Kibballi Madhukeshwar, et al.
Publicado: (2017)

Treating drug-resistant tuberculosis in a low-intensity chronic conflict setting in India
por: Armstrong, Edward, et al.
Publicado: (2014)

When particles collide
por: Jha, Alok
Publicado: (2004)

Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time
por: Dalal, Alpa, et al.
Publicado: (2015)

High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India
por: Andries, Aristomo, et al.
Publicado: (2013)

How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?
por: Burugina Nagaraja, Sharath, et al.
Publicado: (2011)

Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
por: Mehta, Salil, et al.
Publicado: (2016)

Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2013)

Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
por: Laxmeshwar, Chinmay, et al.
Publicado: (2022)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria
por: Oladimeji, Olanrewaju, et al.
Publicado: (2014)

Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India
por: Gill, Naresh, et al.
Publicado: (2019)

Tuberculosis Contact Screening and Isoniazid Preventive Therapy in a South Indian District: Operational Issues for Programmatic Consideration
por: Pothukuchi, Madhavi, et al.
Publicado: (2011)

Employees State Insurance Corporation health camps at Bengaluru, India: Bridging gaps
por: Nagaraja, Sharath Burugina, et al.
Publicado: (2013)

Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
por: Poornima, M. P., et al.
Publicado: (2020)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

Multidrug-Resistant TB in the Philippines: Totem and Taboo
por: Portero, Jose Luis, et al.
Publicado: (2006)

Multidrug-Resistant TB in the Philippines: Authors' Reply
por: Tupasi, Thelma
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_gat15prj8eo1bro4pb2e4ohbna